Search

2020 Community Investment Annual Report
It was clear that 2020 was an extraordinary year, as our members and all healthcare providers dealt with conditions more fitting to a battlefield than healthcare. But as our members met and exceeded the challenges, we were also proud to see our employees and nonprofit partners rise to meet the needs of our communities.

Professional Education
Healthcare AI: Peril or Paradigm?
This program provides nurses with an overview of the range of artificial intelligence models that can potentially be applied in healthcare, examples of regulatory and ethical AI guidance documents, and evidence-based discussions of risks and strategies to address the risks of using AI in healthcare.

Professional Education
You Have Been Served with a Malpractice Lawsuit or a Regulatory Action Notice: Now What?
Malpractice litigation and government regulatory and licensing oversight are inherent aspects of licensed healthcare professionals. The concern regarding malpractice litigation is well-founded, and regulatory and licensing actions can pose significant challenges. Therefore, clinicians must be prepared and knowledgeable about navigating legal notices and taking appropriate steps to ensure compliance. By participating in this program, they can effectively mitigate the impact of claims, complaints, or regulatory actions and safeguard their practice.

Track Legislative Activity
More than 150,000 bills are introduced each year in state and federal legislatures, and we continually monitor legislation that impacts our members and advocate on your behalf. You can sort legislative activity by issue or state.

Communication Resources
Get risk management/patient safety resources and free accredited education on issues surrounding patient-clinician communication.

Professional Education
Loss Lessons: Lithium Toxicity, Fine Tuning Medications Used in Behavioral Health
Lithium therapy can be used for bipolar affective disorders and in depressive disorders where other antidepressants have been unsuccessful. It is considered a “high-risk” drug due to its narrow therapeutic range and potential for overdose toxicity. This case illustrates the pitfalls that occurred resulting in litigation. It is followed by a discussion of the problems that could have been avoided by following safety guidelines for prescribing lithium.

Stay in the Know

Sign Up for The Doctor’s Practice

Our monthly e-newsletter features timely articles, videos, and guides on a range of patient safety topics.

Subscribe